BioSpace News Archive

NexImmune, Inc. announced the closing of its previously announced registered direct offering of 304,731 shares of its common stock at a purchase price of $12.05 per share in a registered direct offering priced at-the-market under Nasdaq rules.

atai Life Sciences announced that Anne Johnson, the Company’s interim Chief Financial Officer since October 2023 and Chief Accounting Officer since August 2022, has been named Chief Financial Officer.

Tyber Medical LLC, a leading orthopedic device manufacturer providing private label orthopedic implants for the trauma, extremity, and spine markets, received clearance for the anatomical plating system in Canada.

SMC Laboratories, Inc. (“SMC Laboratories”) recently launched their innovative STAM™-HCC/IO+ mouse – a first in the field of tumor immuno-oncology – to develop new liver cancer therapeutic drugs.

Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Company executives will participate in the upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference.

Fusion Pharmaceuticals Inc. announced that the compensation committee of the Company’s Board of Directors granted stock option awards to purchase an aggregate of 340,000 shares of its common stock to nine employees outside Fusion’s 2020 Stock Option and Incentive Plan.